EQ
Equillium, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.92
+1.59%Next report
Analyst consensus
- Next report date
- Nov 12, 2026
- EPS estimate
- -$0.05
- Revenue estimate
- —
Latest reported
- Last report date
- Aug 13, 2026
- EPS actual
- -$0.04
- EPS estimate
- -$0.05
- Revenue actual
- —
- Revenue estimate
- —
Track record
Trailing twelve quarters
- EPS beats (12Q)
- 9
- EPS misses (12Q)
- 3
- EPS in line (12Q)
- 0
- Avg surprise (4Q)
- +19.0%
- Revenue beats (12Q)
- 3
Analyst ratings
Sell-side consensus
- Consensus
- Buy
- Price target
- $16
- PT range
- $12 – $20
- Analysts
- 2
2 Buy0 Hold0 Sell
No earnings call summaries available
Reported history
| Report date | EPS estimate | EPS actual | Surprise | Revenue actual |
|---|---|---|---|---|
| Aug 13, 2026 | -$0.05 | -$0.04 | Beat 25.93% | — |
| May 13, 2026 | -$0.04 | -$0.06 | Miss -50.00% | — |
| Mar 25, 2026 | -$0.07 | -$0.04 | Beat 42.86% | — |
| Nov 13, 2025 | -$0.14 | -$0.06 | Beat 57.14% | — |
| Aug 14, 2025 | -$0.14 | -$0.16 | Miss -14.29% | — |
| Mar 27, 2025 | -$0.22 | -$0.16 | Beat 27.27% | $4.4M |
| Nov 13, 2024 | -$0.26 | -$0.00 | Beat 99.92% | $12.2M |
| Aug 8, 2024 | -$0.15 | $0.01 | Beat 106.67% | $13.9M |
| May 9, 2024 | -$0.17 | -$0.08 | Beat 52.94% | $10.7M |
| May 11, 2023 | -$0.20 | -$0.11 | Beat 45.00% | $8.9M |
| Mar 23, 2023 | $0.02 | $0.08 | Beat 407.61% | $15.8M |
| Nov 14, 2022 | -$0.39 | -$0.40 | Miss -2.56% | — |
Reported results against consensus at the time of each report · Surprise is computed from the estimate on record · Data as of Nov 12, 2026